REDWOOD CITY, Calif., Nov. 28, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providinginnovative evidence-based solutions for the treatment of chronic pain, today announced that it has filed a lawsuit for patent infringement against units of Boston Scientific (NYSE:BSX). The lawsuit, filed in the United States District Court for the
"Nevro was founded in 2006 to develop meaningful advances in the treatment of chronic pain to improve patients' lives," said Rami Elghandour, President and CEO of Nevro. "Intellectual property is the basis for innovation in health sciences given the long development timelines, investment, and risk required to bring meaningful advances to market. We are committed to ensuring continued innovation in health sciences by protecting our intellectual property."
Documents relating to the lawsuit can be found via registration at the court's website, www.cand.uscourts.gov. The case no. is 3:16-cv-06830.
Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.
Investor Relations Contact:
Nevro Investor Relations
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nevro-files-lawsuit-for-patent-infringement-against-boston-scientific-in-the-us-300369262.html
SOURCE Nevro Corp.
Subscribe to our Free Newsletters!
A patient's struggle with Issacs' syndrome with no cure. Also known as neuromyotonia it is a rare ...
Inguinal hernia surgery is a procedure to repair a weak spot or defect in the lower wall of the ...
Hypopituitarism is a rare disorder resulting from decreased secretion of one or more of the ...View All